415 related articles for article (PubMed ID: 1334028)
1. Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine.
Morel I; Cillard J; Lescoat G; Sergent O; Pasdeloup N; Ocaktan AZ; Abdallah MA; Brissot P; Cillard P
Free Radic Biol Med; 1992 Nov; 13(5):499-508. PubMed ID: 1334028
[TBL] [Abstract][Full Text] [Related]
2. EPR study of antioxidant activity of the iron chelators pyoverdin and hydroxypyrid-4-one in iron-loaded hepatocyte culture: comparison with that of desferrioxamine.
Morel I; Sergent O; Cogrel P; Lescoat G; Pasdeloup N; Brissot P; Cillard P; Cillard J
Free Radic Biol Med; 1995 Feb; 18(2):303-10. PubMed ID: 7744315
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of iron toxicity in rat and human hepatocyte cultures by the hydroxypyridin-4-ones CP20 and CP94.
Chenoufi N; Hubert N; Loréal O; Morel I; Pasdeloup N; Cillard J; Brissot P; Lescoat G
J Hepatol; 1995 Aug; 23(2):166-73. PubMed ID: 7499788
[TBL] [Abstract][Full Text] [Related]
4. Studies of in vivo iron mobilization by chelators in the ferrocene-loaded rat.
Florence A; Ward RJ; Peters TJ; Crichton RR
Biochem Pharmacol; 1992 Sep; 44(6):1023-7. PubMed ID: 1417929
[TBL] [Abstract][Full Text] [Related]
5. Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: a biological and physicochemical study.
Gaboriau F; Chantrel-Groussard K; Rakba N; Loyer P; Pasdeloup N; Hider RC; Brissot P; Lescoat G
Biochem Pharmacol; 2004 Apr; 67(8):1479-87. PubMed ID: 15041465
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of the protective effect between deferoxamine and deferiprone on chronic iron overload induced cardiotoxicity in rats.
Emara AM; El Kelany RS; Moustafa KA
Hum Exp Toxicol; 2006 Jul; 25(7):375-85. PubMed ID: 16898166
[TBL] [Abstract][Full Text] [Related]
7. The iron chelators desferrioxamine and 1-alkyl-2-methyl-3-hydroxypyrid-4-ones inhibit vascular prostacyclin synthesis in vitro.
Jeremy JY; Kontoghiorghes GJ; Hoffbrand AV; Dandona P
Biochem J; 1988 Aug; 254(1):239-44. PubMed ID: 3140797
[TBL] [Abstract][Full Text] [Related]
8. Chelation of aluminium by combining DFO and L1 in rats.
Blanusa M; Prester L; Varnai VM; Pavlović D; Kostial K; Jones MM; Singh PK
Toxicology; 2000 Jul; 147(3):151-6. PubMed ID: 10924797
[TBL] [Abstract][Full Text] [Related]
9. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
Kontoghiorghes GJ; Sheppard L; Hoffbrand AV; Charalambous J; Tikerpae J; Pippard MJ
J Clin Pathol; 1987 Apr; 40(4):404-8. PubMed ID: 3584483
[TBL] [Abstract][Full Text] [Related]
10. [A comparative study of the antioxidant properties of polyhydroxamic acids, desferal and other iron chelating agents].
Kozlov AV; Meshchanov FIu; Nikolaeva IG; Kol'tsova GN; Vladimirov IuA
Biofizika; 1993; 38(4):708-13. PubMed ID: 8395897
[TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of hydroxypyridone iron chelators in a mouse model.
Gyparaki M; Porter JB; Hirani S; Streater M; Hider RC; Huehns ER
Acta Haematol; 1987; 78(2-3):217-21. PubMed ID: 3120475
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures.
Morel I; Lescoat G; Cogrel P; Sergent O; Pasdeloup N; Brissot P; Cillard P; Cillard J
Biochem Pharmacol; 1993 Jan; 45(1):13-9. PubMed ID: 8424806
[TBL] [Abstract][Full Text] [Related]
13. Novel 21-aminosteroidlike compounds prevent iron-induced free radical-mediated injury to vascular endothelial cells.
Pakala R; Pakala R; Benedict CR
J Cardiovasc Pharmacol; 1995 Jun; 25(6):871-9. PubMed ID: 7564331
[TBL] [Abstract][Full Text] [Related]
14. New modes of action of desferrioxamine: scavenging of semiquinone radical and stimulation of hydrolysis of tetrachlorohydroquinone.
Zhu BZ; Har-El R; Kitrossky N; Chevion M
Free Radic Biol Med; 1998 Jan; 24(2):360-9. PubMed ID: 9433912
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lipid peroxidation by a new family of iron chelators. Comparison with desferrioxamine.
Rachidi S; Coudray C; Baret P; Gelon G; Pierre JL; Favier A
Biol Trace Elem Res; 1994; 41(1-2):77-87. PubMed ID: 7946911
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of iron overload toxicity in rat hepatocyte cultures by pyoverdin Pf, the siderophore of Pseudomonas fluorescens.
Jego P; Hubert N; Morel I; Pasdeloup N; Ocaktan A; Abdallah M; Brissot P; Lescoat G
Biochem Pharmacol; 1992 Mar; 43(6):1275-80. PubMed ID: 1562281
[TBL] [Abstract][Full Text] [Related]
17. Cellular zinc content is a major determinant of iron chelator-induced apoptosis of thymocytes.
Maclean KH; Cleveland JL; Porter JB
Blood; 2001 Dec; 98(13):3831-9. PubMed ID: 11739193
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs.
Kontoghiorghes GJ
Toxicol Lett; 1995 Oct; 80(1-3):1-18. PubMed ID: 7482575
[TBL] [Abstract][Full Text] [Related]
19. Iron complexes of deferiprone and dietary plant catechols as cytoprotective superoxide radical scavengers(1).
Moridani MY; O'Brien PJ
Biochem Pharmacol; 2001 Dec; 62(12):1579-85. PubMed ID: 11755110
[TBL] [Abstract][Full Text] [Related]
20. Ability of the orally effective iron chelators dimethyl- and diethyl-hydroxypyrid-4-one and of deferoxamine to restore sarcolemmal thiolic enzyme activity in iron-loaded heart cells.
Link G; Pinson A; Hershko C
Blood; 1994 May; 83(9):2692-7. PubMed ID: 8167347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
